CMPO vs PFE · rev $420.6M vs P/E 20, rev $62.58B
CompoSecure, Inc. (CMPO) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
CompoSecure, Inc. (CMPO) is a metal fabrication company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CMPO revenue for 2024-12-31 was $420.6M. Net income was -$83.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. CMPO currently screens at market cap $7.28B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CMPO currently screens at market cap $7.28B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CMPO and PFE stock pages for the full models.
Not investment advice.